MedPath

Effects of syrup of Jollab on fatigue in patients with breast cancer

Phase 3
Conditions
eoplastic (malignant) related fatigue.
Neoplastic (malignant) related fatigue
Registration Number
IRCT20150825023753N8
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Female gender
Age between 18- 70 years old
Patients known case of breast cancer
Hemoglobin level is at least 8 g / dl
Hematocrit level at least 30%
The level of TSH is normal

Exclusion Criteria

Patients known case of heart disease with unstable conditions
Disabling Pulmonary Disease and History of Asthma
Patients known case of severe kidney disease
Creatinine level is greater than 2mg / dl
Proteinuria
The SGOT level is more than 3 times of the normal threshold
Bilirubin levels is greater than 2mg / dl
Positive history of hypersensitivity to saffron, Rose water and Honey
Uncontrolled pain, severe infection, serious illness
Positive history of gout or high level of uric acid
An individual who uses antidepressants due to depression
Simultaneous use of drugs that affect fatigue
Unwillingness to participate in the study
Active treatment for anemia (transfusion or Epoetin Alfa Injection)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Score of Fatigue Severity Visual Analogue Fatigue Scale. Timepoint: The weeks of 0 and 4 after treatment. Method of measurement: Using Visual Analogue Fatigue Scale questionnaire.;Score of Fatigue Severity. Timepoint: The weeks of 0 and 4 after treatment. Method of measurement: Fatigue Severity Scale questionnaire.;Score of The Cancer Fatigue Scale. Timepoint: The weeks of 0 and 4 after treatment. Method of measurement: The Cancer Fatigue Scale questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath